AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 7014058
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of aspirin and hydroxychloroquine (Plaquenil), 300 mg, b.i.d.
Trial: 28966304
Drug: Mild hypothermia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mild hypothermia therapy (34‐36°C)
Trial: 25467190
Drug: Gabapentin enacarbil
RxNorm normalized name: Gabapentin Enacarbil
DrugBank: Gabapentin enacarbil (DB08872)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gabapentin enacarbil (GEn) 600 mg + morphine placebo
Trial: 25467190
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment (GEn + morphine)
Trial: 21317209
Drug: No pre-treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No pre-treatment with etch-and-rinse adhesive system (Transbond XT)
Trial: 21317209
Drug: No pre-treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No pre-treatment with self-etching adhesive system (Transbond Plus)
Trial: 17845276
Drug: Topiramate (100-400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate (100-400 mg/day)
Trial: 28524705
Drug: Intensive individualized
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive individualized nutritional and educational interventions during the entire course of chemotherapy
Trial: 30767826
Drug: High-Intensity Treatment
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-Intensity Treatment (HIT)
Trial: 30767826
Drug: Low-Intensity Treatment
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-Intensity Treatment (LIT)
Trial: 17869635
Drug: Dabigatran etexilate
RxNorm normalized name: Dabigatran etexilate
DrugBank: Dabigatran etexilate (DB06695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dabigatran etexilate 220 mg
Trial: 23519576
Drug: Dabigatran etexilate
RxNorm normalized name: Dabigatran etexilate
DrugBank: Dabigatran etexilate (DB06695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dabigatran etexilate 150 mg
Trial: 16855074
Drug: FTY720 1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FTY720 1.25 mg
Trial: 16855074
Drug: FTY720 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FTY720 5 mg
Trial: 16855074
Drug: FTY720 (1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FTY720 (1.25 mg or 5 mg)
Trial: 10426879
Drug: Statin treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin treatment (Simvastatin)
Trial: 10426879
Drug: Statin treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin treatment (not specified)
Trial: 10426879
Drug: Statin treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin treatment (Pravastatin)
Trial: 2967477
Drug: Prednisone 30
RxNorm normalized name: prednisone 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone 30 mg
Trial: 7482385
Drug: Dextroamphetamine 15
RxNorm normalized name: dextroamphetamine 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextroamphetamine 15 mg
Trial: 28533100
Drug: Remote ischaemic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remote ischaemic conditioning (RIC) treatment, performed twice a day for 6 weeks
Trial: 27914656
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg oral omecamtiv mecarbil twice daily (fixed-dose group)
Trial: 27914656
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg twice daily titrated to 50 mg twice daily (pharmacokinetic-titration group)
Trial: 27914656
Drug: Pharmacokinetic-titration group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacokinetic-titration group
Trial: 16105530
Drug: 0.5 microg
RxNorm normalized name: calcitriol 0.5 MICROGRAM In 1 CAPSULE ORAL CAPSULE, LIQUID FILLED [Rocaltrol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 microg of calcitriol twice per day (group A)
Trial: 2047050
Drug: Low-dose triphasic
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose triphasic oral contraceptives (ethinyl estradiol and levonorgestrel)
Trial: 2047050
Drug: Low-dose triphasic
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose triphasic oral contraceptives (ethinyl estradiol and norethindrone)
Trial: 25761430
Drug: Amlodipine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine (10 mg p.d.)
Trial: 25761430
Drug: Ranolazine (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranolazine (750 mg b.i.d.)
Trial: 21323491
Drug: Tailored fluorouracil,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tailored fluorouracil, epirubicin, and cyclophosphamide (FEC) therapy at dose step 4
Trial: 21323491
Drug: Tailored fluorouracil,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tailored fluorouracil, epirubicin, and cyclophosphamide (FEC) therapy at dose steps -2 and -1 (combined)
Trial: 21323491
Drug: Tailored fluorouracil,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tailored fluorouracil, epirubicin, and cyclophosphamide (FEC) therapy (all dose steps)
Trial: 20306761
Drug: Chemical medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemical medicine (not specified)
Trial: 20306761
Drug: Placebo (inert
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (inert pill)
Trial: 7948453
Drug: Antipsychotic medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antipsychotic medication
Trial: 31664343
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy (45 minutes) and sham VR program (15 minutes)
Trial: 23835207
Drug: Governmentally-led physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Governmentally-led physical activity program (Youp'là Bouge) implemented in 58 child care centers, including training of educators, adaptation of the built environment, parental involvement, and daily physical activity from September 2009 to June 2010.
Trial: 9659302
Drug: Healing sessions
RxNorm normalized name: Alternanthera sessilis extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Healing sessions (10 weekly sessions)
Trial: 6790048
Drug: Oxprenolol (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxprenolol (40 mg)
Trial: 19433558
Drug: Posaconazole administered
RxNorm normalized name: Posaconazole
DrugBank: Posaconazole (DB01263)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Posaconazole administered via nasogastric tube (400 mg)
Trial: 19433558
Drug: Posaconazole administered
RxNorm normalized name: Posaconazole
DrugBank: Posaconazole (DB01263)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Posaconazole administered orally (400 mg)
Trial: 10952323
Drug: Heparin group
RxNorm normalized name: Heparin group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin group
Trial: 4038553
Drug: Oral dexamethasone
RxNorm normalized name: dexamethasone Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral dexamethasone (2-week tapering dose from 0.15 mg/kg/d)
Trial: 27817208
Drug: Liraglutide 3.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liraglutide 3.0 mg
Trial: 17506591
Drug: Imidapril (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imidapril (5 mg/day to 20 mg/day)
Trial: 17506591
Drug: Candesartan cilexetil
RxNorm normalized name: Candesartan Cilexetil
DrugBank: Candesartan cilexetil (DB00796)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Candesartan cilexetil (4 mg/day to 16 mg/day)
Trial: 31133052
Drug: Intravenous hydration
RxNorm normalized name: Chloral Hydrate
DrugBank: Chloral hydrate (DB01563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous hydration (aggressive or routine)
Trial: 15649850
Drug: Oral slow-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral slow-release theophylline (Theo-Dur, 600 mg tablets)
Trial: 15649850
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of salmeterol and theophylline
Trial: 15649850
Drug: Theophylline (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline (600 mg)
Trial: 11960266
Drug: Blood stem
RxNorm normalized name: Autologous Hematopoietic Peripheral Blood Stem Cells
DrugBank: Autologous Hematopoietic Peripheral Blood Stem Cells (DB17067)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood stem cell (BSC) donation with G-CSF 10 microg/kg s.c., daily for 5 days before leukapheresis
Trial: 8602746
Drug: Interferon beta‐1a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon beta‐1a (6.0 million units, 30 micrograms, administered by intramuscular injection weekly)
Trial: 20472939
Drug: Surfactant treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surfactant treatment
Trial: 2011088
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy with mechanical ventilation alone (Control)
Trial: 7156001
Drug: Double blind
RxNorm normalized name: Io-Blend
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double blind ribosomal vaccine
Trial: 25268853
Drug: Transdermal 17β
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal 17β estradiol (t‐E2) 50 μg/day plus micronized progesterone (m‐P) for 12 days
Trial: 25268853
Drug: Oral conjugated
RxNorm normalized name: Conjugated Estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral conjugated equine estrogen (o‐CEE) 0.45 mg/day plus micronized progesterone (m‐P) for the first 12 days of the month
Trial: 9477042
Drug: Daflon 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daflon 500 mg
Trial: 30139537
Drug: Patient selection
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient selection by the number of prescribed drugs
Trial: 17545008
Drug: Calcineurin inhibitors
RxNorm normalized name: Calcineurin inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcineurin inhibitors
Trial: 17499035
Drug: Intracavity triamcinolone
RxNorm normalized name: Triamcinolone
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracavity triamcinolone 80 mg (Group A, n=29)
Trial: 17499035
Drug: Intracavity triamcinolone
RxNorm normalized name: Triamcinolone
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracavity triamcinolone 80 mg (Group A)
Trial: 12798615
Drug: vax‐TyVi (Salmonella
FDA approved: no
EMA approved: no
PMDA approved: no
Description: vax‐TyVi (Salmonella Typhi Vi polysaccharide vaccine)
Trial: 8179456
Drug: Transdermal nicotine
RxNorm normalized name: nicotine Transdermal System
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal nicotine (14 mg/d, increased to 21 mg/d if smoking more than seven cigarettes after 1 week)
Trial: 2851195
Drug: Standard heparin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard heparin, 5,000 I.U.
Trial: 29110647
Drug: Omarigliptin 25
RxNorm normalized name: Omarigliptin
DrugBank: Omarigliptin (DB11992)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Omarigliptin 25 mg once-weekly
Trial: 15621114
Drug: C(2) of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C(2) of 1043 +/- 151 ng/mL or AUC(0-4) of 3146 +/- 262 ng . h/mL (with induction therapy)
Trial: 15621114
Drug: Induction therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction therapy with basiliximab or thymoglobulin
Trial: 11212082
Drug: Other GnRH
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Other GnRH agonists
Trial: 30127595
Drug: Candesartan 32
RxNorm normalized name: candesartan 32 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan 32 mg alone
Trial: 21394036
Drug: Amlodipine 10
RxNorm normalized name: amlodipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine 10 mg alone
Trial: 30127595
Drug: Candesartan 32
RxNorm normalized name: candesartan 32 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan 32 mg and Amlodipine 10 mg co-administration
Trial: 18369721
Drug: Two types
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two types of sex (vaginal plus oral or anal)
Trial: 9603075
Drug: Pneumococcal vaccine
RxNorm normalized name: PNEUMOCOCCAL VACCINE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pneumococcal vaccine administered at 14 days post-splenectomy
Trial: 8554468
Drug: Peroneal stimulator
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peroneal stimulator (PS) during treatment period
Trial: 2675496
Drug: Magnesium (Mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium (Mg 5‐longoral, Artesan GmbH)
Trial: 30982447
Drug: Synbiotic supplementation
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Synbiotic supplementation (2.0 × 10^8 CFU probiotics and 394 mg fructooligosaccharide)
Trial: 20845670
Drug: Total intravenous
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total intravenous anesthesia with propofol (group T)
Trial: 16144748
Drug: 16 mg
RxNorm normalized name: escin 16 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 16 mg buprenorphine tablets (two 8 mg tablets)
Trial: 16144748
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg buprenorphine solution (1 ml at 8 mg/ml)
Trial: 11144006
Drug: Cisapride (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride (20 mg twice daily for 6 months)
Trial: 10071518
Drug: cetirizine 10
RxNorm normalized name: cetirizine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cetirizine 10 mg
Trial: 10071518
Drug: loratadine 10
RxNorm normalized name: loratadine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: loratadine 10 mg
Trial: 2906345
Drug: LNG-containing pill
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LNG-containing pill
Trial: 2906345
Drug: GTD-containing pill
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GTD-containing pill
Trial: 28095580
Drug: 4% Hydroquinone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% Hydroquinone lightening solution (OB)
Trial: 25137843
Drug: Jiawei Shentong
RxNorm normalized name: camphor
DrugBank: Camphor (DB01744)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Jiawei Shentong Zhuyu Decoction (JSZD), one dose per day, taken in two portions (morning and evening) for 30 days
Trial: 25137843
Drug: Celecoxib Capsule
RxNorm normalized name: Celecoxib Capsules
DrugBank: Celecoxib (DB00482)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Celecoxib Capsule (200 mg once per day) and Mecobalamin Tablet (0.5 mg three times per day, only Mecobalamin from day 11) for 30 days
Trial: 20384423
Drug: Nicotine (1.14
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine (1.14 mg nicotine, 15.9 mg tar)
Trial: 20384423
Drug: Denicotinized cigarettes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Denicotinized cigarettes (.06 mg nicotine, 17.9 mg tar)
Trial: 20384423
Drug: Alcohol (men:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol (men: 0.8 g/kg; women: 0.7 g/kg)
Trial: 18520312
Drug: Chronic care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chronic care intervention for depression treatment
Trial: 7723385
Drug: Late intensification
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Late intensification plus monthly maintenance
Trial: 1904551
Drug: Ribavirin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ribavirin (20 mg per milliliter) administered continuously in aerosolized form
Trial: 18292438
Drug: Clonidine infusion
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clonidine infusion at a rate ranging from 6 to 10 microg x kg(‐1) x h(‐1)
Trial: 10762110
Drug: Zanamivir 10
RxNorm normalized name: Zanamivir 10 mg/mL solution for infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zanamivir 10 mg via Diskhaler twice daily for 5 days
Trial: 9692103
Drug: Ciprofloxacin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin (500 mg b.d.)
Trial: 8697891
Drug: Amoxycillin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxycillin (1 g t.d.s.)
Trial: 8207744
Drug: Verapamil 360
RxNorm normalized name: verapamil 360 mg/24 hours oral capsule, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil 360 mg per day
Trial: 6376210
Drug: Oral N-acetylcysteine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral N-acetylcysteine (Fabrol)
Trial: 3915163
Drug: Dipyridamole (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dipyridamole (single dose)
Trial: 3915163
Drug: Dipyridamole (multidose,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dipyridamole (multidose, three times daily)
Trial: 3915163
Drug: Placebo (multidose,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (multidose, three times daily)
Trial: 24858952
Drug: Full rapid-acting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full rapid-acting insulin dose
Trial: 24858952
Drug: 50% reduced
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50% reduced rapid-acting insulin dose
Trial: 18328014
Drug: Flaxseed (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flaxseed (30 g daily for 3 months)
Trial: 10100079
Drug: 0.02 mg
RxNorm normalized name: escin 0.02 MG/MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.02 mg ethinyloestradiol
Trial: 10100079
Drug: 0.625 mg
RxNorm normalized name: estrone 0.625 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.625 mg oestrone sulphate
Trial: 10100079
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg oestrone sulphate
Trial: 10100079
Drug: High-dose oestrone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose oestrone
Trial: 8914356
Drug: Topical fluticasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical fluticasone propionate 0.05% cream
Trial: 1796230
Drug: Ivermectin at
RxNorm normalized name: Ivermectin
DrugBank: Ivermectin (DB00602)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ivermectin at 100 mcg/kg
Trial: 25251800
Drug: Chest physical
RxNorm normalized name: Kids-Eeze Chest Relief
DrugBank: Guaifenesin (DB00874)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chest physical therapy program
Trial: 20136919
Drug: Topical Boswellic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical Boswellic acids (0.5% BAs)
Trial: 20136919
Drug: Placebo (base
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (base cream without BAs)
Trial: 10745577
Drug: Ticlopidine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticlopidine treatment
Trial: 365775
Drug: 500 IU
RxNorm normalized name: Vitamin E 500 IU Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 IU of the influenza subunit vaccine
Trial: 365775
Drug: 1000 IU
RxNorm normalized name: D 1000 IU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 IU of the influenza subunit vaccine
Trial: 365775
Drug: 2000 IU
RxNorm normalized name: D 2000 IU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2000 IU of the influenza subunit vaccine
Trial: 28278391
Drug: Indacaterol/glycopyrronium (110/50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indacaterol/glycopyrronium (110/50 μg once daily)
Trial: 28278391
Drug: Salmeterol/fluticasone (50/500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol/fluticasone (50/500 μg twice daily)
Trial: 19028707
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg kg(‐1) of ketamine
Trial: 1743250
Drug: Cefadroxil 15
RxNorm normalized name: Cefadroxil
DrugBank: Cefadroxil (DB01140)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefadroxil 15 mg.kg‐1
Trial: 1743250
Drug: Cefadroxil 5
RxNorm normalized name: cefadroxil 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefadroxil 5 mg.kg‐1 with Cephalexin 45 mg.kg‐1
Trial: 6790688
Drug: Intermittent oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent oral feeding
Trial: 11906804
Drug: Ketoconazole (600-900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoconazole (600-900 mg daily)
Trial: 30848096
Drug: 31 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 31 g of milk protein supplementation for 12 weeks
Trial: 22128076
Drug: Daily oral
RxNorm normalized name: GEMTESA 75 MG Once-Daily Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily oral cyclophosphamide (DO)
Trial: 405998
Drug: 10% sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% sodium cromoglycate ointment
Trial: 405998
Drug: Placebo ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo ointment (white soft-paraffin base only)
Trial: 18553033
Drug: Tepid sponging
RxNorm normalized name: spongia tosta
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tepid sponging plus dipyrone (20 mg/kg) for 15 minutes
Trial: 15724045
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg elemental zinc supplementation